← Back to home

ADVANCED GASTRIC CANCER/GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA AND OTHER SOLID TUMORS

Clinical trials for ADVANCED GASTRIC CANCER/GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA AND OTHER SOLID TUMORS explained in plain language.

Never miss a new study

Get alerted when new ADVANCED GASTRIC CANCER/GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA AND OTHER SOLID TUMORS trials appear

Sign up with your email to follow new studies for ADVANCED GASTRIC CANCER/GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA AND OTHER SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New Two-Drug attack on advanced stomach cancer enters testing

Disease control Recruiting now

This study is testing whether a new drug called glumetinib, when combined with an existing chemotherapy (docetaxel), can help control advanced stomach, gastroesophageal, and other solid tumors that have a specific genetic feature (MET overexpression/amplification). It aims to fin…

Matched conditions: ADVANCED GASTRIC CANCER/GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA AND OTHER SOLID TUMORS

Phase: PHASE2 • Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. • Aim: Disease control

Last updated Mar 13, 2026 15:05 UTC

ADVANCED GASTRIC CANCER/GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA AND OTHER SOLID TUMORS

Get alerted when new ADVANCED GASTRIC CANCER/GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA AND OTHER SOLID TUMORS trials appear

New Two-Drug attack on advanced stomach cancer enters testing